Target intelligence / Profile preview

Cutaneous T-cell lymphoma-associated antigen 1 pseudogene (CTAGE1 pseudogene)

Target
CTAGE1 pseudogene
Molecular classification
Pseudogene
01

Overview

Cutaneous T-cell lymphoma-associated antigen 1 pseudogene (ENSG00000274549) is a non-coding genomic segment located in the human genome. It is related by sequence homology to the CTAGE1 gene, which encodes a tumor-associated antigen expressed in cutaneous T-cell lymphoma and certain other malignancies. However, as a pseudogene, ENSG00000274549 does not encode a functional protein, and there is no direct evidence for it serving a regulatory or pathological role. Pseudogenes are generally regarded as nonfunctional remnants of genes that have accumulated mutations preventing protein expression, though some pseudogenes can modulate gene expression at the RNA level in rare cases. This specific pseudogene is not regarded as a therapeutic target, nor is it directly implicated in disease biology or used as a biomarker. ENSG00000274549, the "cutaneous T-cell lymphoma-associated antigen 1 pseudogene," is a nonfunctional pseudogene and should not be considered a therapeutic target. It is properly classified as a pseudogene, with no established protein expression, therapeutic relevance, or associated drugs. If you are seeking information on a druggable cancer target, you likely wish to refer to the closely related protein-coding gene CTAGE1.

Other names
CTAGE1 pseudogeneCutaneous T-cell lymphoma-associated antigen 1 pseudogene
02

Biological functions

Other (potential regulatory roles at the RNA level, as reported for some pseudogenes, but no evidence for a functional protein product for this specific entry)
03

Disease associations

Other (the parental gene CTAGE1 is discussed in the context of cancer, but this pseudogene itself lacks direct evidence for a functional role in disease)

Beyond the preview

Go deeper on Cutaneous T-cell lymphoma-associated antigen 1 pseudogene (CTAGE1 pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutaneous T-cell lymphoma-associated antigen 1 pseudogene (CTAGE1 pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call